Hiroko Ohgaki
Hiroko Ohgaki
Verified email at iarc.fr
Cited by
Cited by
The 2007 WHO classification of tumours of the central nervous system
DN Louis, H Ohgaki, OD Wiestler, WK Cavenee, PC Burger, A Jouvet, ...
Acta neuropathologica 114 (2), 97-109, 2007
The 2016 World Health Organization classification of tumors of the central nervous system: a summary
DN Louis, A Perry, G Reifenberger, A Von Deimling, D Figarella-Branger, ...
Acta neuropathologica 131 (6), 803-820, 2016
WHO classification of tumours of the central nervous system
WK Cavenee, DN Louis, H Ohgaki, OD Wiestler
WHO Regional Office Europe, 2007
Pathology and genetics of tumours of the nervous system
P Kleihues, WK Cavenee
International Agency for Research on Cancer, 2000
Genetic pathways to primary and secondary glioblastoma
H Ohgaki, P Kleihues
The American journal of pathology 170 (5), 1445-1453, 2007
Genetic pathways to glioblastoma: a population-based study
H Ohgaki, P Dessen, B Jourde, S Horstmann, T Nishikawa, PL Di Patre, ...
Cancer research 64 (19), 6892-6899, 2004
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas
H Ohgaki, P Kleihues
Journal of Neuropathology & Experimental Neurology 64 (6), 479-489, 2005
Epidemiology and etiology of gliomas
H Ohgaki, P Kleihues
Acta neuropathologica 109 (1), 93-108, 2005
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas
T Watanabe, S Nobusawa, P Kleihues, H Ohgaki
The American journal of pathology 174 (4), 1149-1153, 2009
WHO classification of tumours of endocrine organs
IARC, 2017
Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas
K Watanabe, O Tachibana, K Sato, Y Yonekawa, P Kleihues, H Ohgaki
Brain pathology 6 (3), 217-223, 1996
The definition of primary and secondary glioblastoma
H Ohgaki, P Kleihues
Clinical cancer research 19 (4), 764-772, 2013
Primary and secondary glioblastomas: from concept to clinical diagnosis
P Kleihues, H Ohgaki
Neuro-oncology 1 (1), 44-51, 1999
IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas
S Nobusawa, T Watanabe, P Kleihues, H Ohgaki
Clinical Cancer Research 15 (19), 6002-6007, 2009
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype
M Olivier, DE Goldgar, N Sodha, H Ohgaki, P Kleihues, P Hainaut, ...
Cancer research 63 (20), 6643-6650, 2003
Tumors associated with p53 germline mutations: a synopsis of 91 families.
P Kleihues, B Schäuble, A zur Hausen, J Estève, H Ohgaki
The American journal of pathology 150 (1), 1, 1997
I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading
DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ...
Brain pathology 24 (5), 429-435, 2014
Genetic alterations and signaling pathways in the evolution of gliomas
H Ohgaki, P Kleihues
Cancer science 100 (12), 2235-2241, 2009
Epidemiology of brain tumors
H Ohgaki
Cancer Epidemiology, 323-342, 2009
Cell and molecular biology of simian virus 40: implications for human infections and disease
JS Butel, JA Lednicky
Journal of the National Cancer Institute 91 (2), 119-134, 1999
The system can't perform the operation now. Try again later.
Articles 1–20